A.J. Day, PharmD, PCCA Vice President of Clinical Services, joins Mike and Sebastian to discuss various details of federal oversight on 503A compounding as well as an important FDA ruling on several bulk substances related to compounding for human use, which goes into effect on March 21, 2019.
Comments (3)
More Episodes
All Episodes>>
Get this podcast on your phone, Free
Creat Yourt Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
